Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 6 stocks made the list for top value stocks in the Healthcare Facilities & Services industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.

Why Focus on Undervalued Healthcare Facilities & Services Stocks?

Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.

AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

What Goes Into AAII’s Value Grade?

Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.

Click the button below to learn more about A+ Investor and subscribe today.

6 Undervalued Healthcare Facilities & Services Stocks

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Healthcare Facilities & Services industry for Thursday, August 08, 2024. Let’s take a closer look at their individual scores to see how they measure up against each other and the Healthcare Facilities & Services industry median.

The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.

The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)

Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).

As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.

Americann Inc’s Value Grade

Value Grade:

AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Americann Inc has a Value Score of 83, which is considered to be undervalued.

When you look at Americann Inc’s price-to-sales ratio at 0.33 compared to the industry median at 1.10, this company has a lower price relative to revenue compared to its peers. This could make Americann Inc’s stock more attractive for value investors.

Now, let’s assess Americann Inc’s EV/EBITDA ratio, also known as enterprise multiple. At 12.1, when compared to the industry median of 12.1, the company may be considered fairly valued in relation to its peers. Value investors could use the enterprise multiple to identify stocks that are considered overvalued or undervalued relative to their industry.

Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. Americann Inc’s shareholder yield is higher than its industry median ratio of (1.50%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.

As one of the most common value metrics, the price-to-book ratio evaluates a company’s current market price relative to its book value. Americann Inc’s price-to-book ratio is lower than its industry median ratio of 2.24. This could make Americann Inc more attractive to investors looking for a new addition to their portfolio.

Aveanna Healthcare Holdings Inc’s Value Grade

Value Grade:

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platform. The Company provides a range of specialized clinical care and non-clinical services to address the complex needs of each patient it serves across the full range of patient populations: newborns, children, adults and seniors. It has three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment provides home health, hospice and specialty program services to predominately elderly populations seeking compassionate care and assistance with activities of daily living in the home. Medical Solutions segment provide needed supplies to patients requiring enteral nutrition services or respiratory care. Enteral nutrition (tube or intravenous (IV)) feeding, is a way of delivering nutrition directly to the stomach or small intestine on an as-needed basis.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Aveanna Healthcare Holdings Inc has a Value Score of 70, which is considered to be undervalued.

You can read more about Aveanna Healthcare Holdings Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Target Group Inc’s Value Grade

Value Grade:

Target Group Inc. is a cannabis and hemp consumer packaged goods (CPG) company. The Company is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada and in the United States. Its products include Cannabis flower pods for vaporizer use, Cannabis extract pods for vaporizer use, Cannabis pre-rolls, K-Cup infused coffee and tea pots, Infused cannabis beverages, Infused cannabis edibles and infused topical products and CBD wellness products. The Company's subsidiary, Canary Rx Inc, is a Canadian licensed producer, which operates an approximately 44,000 square foot facility located in Norfolk County, Ontario. The Company's subsidiary, CannaKorp Inc., has developed a single-use pre-measured pod and vaporizer system, such as The Wisp and Wisp Pods for consumers interested in vaporizing natural herbs, including cannabis.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Target Group Inc has a Value Score of 63, which is considered to be undervalued.

Target Group Inc’s price-earnings ratio is 15.4 compared to the industry median at 23.1. This means that it has a lower price relative to its earnings compared to its peers. This makes Target Group Inc more attractive for value investors.

You can read more about Target Group Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

DLH Holdings Corp’s Value Grade

Value Grade:

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, enterprise-edge information technology (IT) management, health IT systems, performance-based logistics and robotics and unmanned systems.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

DLH Holdings Corp has a Value Score of 61, which is considered to be undervalued.

DLH Holdings Corp’s price-earnings ratio is 63.6 compared to the industry median at 23.1. This means that it has a higher price relative to its earnings compared to its peers. This makes DLH Holdings Corp less attractive for value investors.

DLH Holdings Corp’s price-to-book ratio is higher than its peers. This could make DLH Holdings Corp less attractive for value investors when compared to the industry median at 2.24.

You can read more about DLH Holdings Corp’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

HCA Healthcare Inc’s Value Grade

Value Grade:

HCA Healthcare, Inc. is a health care services company. The Company owns, manages or operates hospitals, freestanding surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. It also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices and other facilities. It operates about 186 hospitals, comprised of 178 general, acute care hospitals, six behavioral hospitals and two rehabilitation hospitals.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

HCA Healthcare Inc has a Value Score of 62, which is considered to be undervalued.

HCA Healthcare Inc’s price-earnings ratio is 16.5 compared to the industry median at 23.1. This means that it has a lower price relative to its earnings compared to its peers. This makes HCA Healthcare Inc more attractive for value investors.

You can read more about HCA Healthcare Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Oncology Institute Inc’s Value Grade

Value Grade:

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Oncology Institute Inc has a Value Score of 88, which is considered to be undervalued.

Oncology Institute Inc’s price-to-book ratio is higher than its peers. This could make Oncology Institute Inc less attractive for value investors when compared to the industry median at 2.24.

You can read more about Oncology Institute Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Other Healthcare Facilities & Services Stock Grades

Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.

Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Healthcare Facilities & Services stocks as well as other industrys.

Choosing Which of the 6 Best Healthcare Facilities & Services Stocks Is Right for You

Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.

• Americann Inc stock has a Value Grade of A.
• Aveanna Healthcare Holdings Inc stock has a Value Grade of B.
• Target Group Inc stock has a Value Grade of B.
• DLH Holdings Corp stock has a Value Grade of B.
• HCA Healthcare Inc stock has a Value Grade of B.
• Oncology Institute Inc stock has a Value Grade of A.

Now that you have a bit more background about each of the 6 undervalued stocks in the Healthcare Facilities & Services industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.

We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.

A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

Additional Resources About Healthcare Facilities & Services Stocks

Want to learn more about Healthcare Facilities & Services stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.

• 6 Undervalued Healthcare Facilities & Services Stocks for Thursday, August 08
• 3 Undervalued Healthcare Facilities & Services Stocks for Wednesday, August 07
• What You Need to Know About CVS Health Corp's Q2 Earnings
• What You Need to Know About R1 Rcm Inc's Q2 Earnings

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.